Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Abstract

loading...

About

This paper, published in 1950, received 833 indexed citations. Written by Alexander D. Douglas, Andrew R. Williams, Joseph J. Illingworth, Gathoni Kamuyu, Sumi Biswas, Anna L. Goodman, David Wyllie, Cécile Crosnier, Kazutoyo Miura and Gavin J. Wright covering the research area of . It is primarily cited by scholars working on Materials Chemistry (200 citations), Electrical and Electronic Engineering (173 citations) and Molecular Biology (150 citations). Published in Nature Communications.

Countries where authors are citing Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Since Specialization
Citations

This map shows the geographic impact of Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody more than expected).

Fields of papers citing Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/ncomms3355.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026